The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
about
Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?A novel role for p120 catenin in E-cadherin functionMolecular Portrait of the Normal Human Breast Tissue and Its Influence on Breast CarcinogenesisDynamic interplay between adhesion surfaces in carcinomas: Cell-cell and cell-matrix crosstalkEpithelial to Mesenchymal Transition in a Clinical PerspectiveBreast cancer epithelial-to-mesenchymal transition: examining the functional consequences of plasticityE-cadherin's dark side: possible role in tumor progressionTargeting γ-secretase in breast cancerComputer simulations of cell sorting due to differential adhesionAdhesion in mammary development: novel roles for E-cadherin in individual and collective cell migrationTwist1-induced dissemination preserves epithelial identity and requires E-cadherin.Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamicsDLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activityCDA: combinatorial drug discovery using transcriptional response modulesInteractions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasisElevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas.BMP-6 promotes E-cadherin expression through repressing deltaEF1 in breast cancer cells.Proteomic characterization of the interstitial fluid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery.Functional characterization of E- and P-cadherin in invasive breast cancer cells.Hyperoxic treatment induces mesenchymal-to-epithelial transition in a rat adenocarcinoma model.Expression analysis of E-cadherin, Slug and GSK3beta in invasive ductal carcinoma of breast.Monoclonal antibody against the ectodomain of E-cadherin (DECMA-1) suppresses breast carcinogenesis: involvement of the HER/PI3K/Akt/mTOR and IAP pathwaysVitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysisInterplay between neural-cadherin and vascular endothelial-cadherin in breast cancer progression.Expression of SATB1 promotes the growth and metastasis of colorectal cancer.Estrogen receptor silencing induces epithelial to mesenchymal transition in human breast cancer cells.Netrin-1 induces MMP-12-dependent E-cadherin degradation via the distinct activation of PKCα and FAK/Fyn in promoting mesenchymal stem cell motility.Estrogen-dependent gallbladder carcinogenesis in LXRbeta-/- female mice.Activation status of Wnt/ß-catenin signaling in normal and neoplastic breast tissues: relationship to HER2/neu expression in human and mouseN-terminal 1-54 amino acid sequence and Armadillo repeat domain are indispensable for P120-catenin isoform 1A in regulating E-cadherin.Phenotypic reversion or death of cancer cells by altering signaling pathways in three-dimensional contextsEnhanced down-regulation of ALCAM/CD166 in African-American Breast Cancer.Common protein biomarkers assessed by reverse phase protein arrays show considerable intratumoral heterogeneity in breast cancer tissues.Invasive Lobular Carcinomas Do Not Express Basal Cytokeratin Markers CK5/6, CK14 and CK17.An immunohistochemically positive E-cadherin status is not always predictive for a good prognosis in human breast cancerDisseminated breast cancer cells acquire a highly malignant and aggressive metastatic phenotype during metastatic latency in the bone.The Expression of the Zonula Adhaerens Protein PLEKHA7 Is Strongly Decreased in High Grade Ductal and Lobular Breast Carcinomas.Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapyTranscriptional shift identifies a set of genes driving breast cancer chemoresistanceAberrant P-cadherin expression is associated to aggressive feline mammary carcinomas
P2860
Q24612630-C24C6A12-B219-4B72-A9F0-C432B3570AA6Q24674430-58B7F34E-992D-4E56-BE2E-2A5F51713EB8Q26744296-4386DB48-F7CC-46B4-8115-1FF59F169833Q26765201-B63DF346-1988-4920-88DA-FE12914206F3Q26783554-35DA4169-1ABA-40CF-AE82-53C3EA2B90AAQ26851620-009CF076-66A6-4ACA-B661-8310419191A5Q26865483-DE500082-9059-424D-A38C-7DA719A1AEE2Q27001056-8295CE8D-E740-4DFB-9329-8DFBE0A1F240Q27319573-FFB21AF4-7CAC-4BEC-9736-5C70F4109CBBQ28087050-FF1DAD8A-2043-488A-915C-7DD7C99AF1A0Q28308198-5FB95384-4EFD-42FA-B7C4-A70FD93E0346Q28383242-7427255D-1B83-4B0E-B7C9-2ABC6DE03651Q28385400-7C222BF5-F3FF-4AC1-A1C9-B8EA6F60F5A9Q28482122-0068A2C7-137C-4FFB-A35C-CC5F7D57D490Q30582061-A2F7F53E-6007-40E5-8E11-5564AC14C46EQ30655673-12934026-92CB-438B-B559-2578277F85D3Q30838242-BB000272-E839-4ABE-B922-497BCF2871A2Q31039477-D2881A4A-44C4-4CDC-A71F-45AEE48A8999Q33414412-DE966235-8DA2-47B9-B55E-35DCF216E582Q33487733-10F8ECD3-BB28-4B35-8825-8C0D0F8F9168Q33502878-7E850FE4-5AA1-4179-A26E-EBFD7A5BA900Q33584432-A7804357-AFBF-45C2-A5A9-68D3CD6C770CQ33682919-A8FF36B2-532B-46C5-A870-A3AFFB9EDE87Q33739421-12BB946B-58C0-4D3C-B4EA-30F5CB1BF0F9Q33817200-914D651B-2935-4373-99BF-32C1D5AA6FC1Q33945493-B2ECCDC4-57D3-493C-BD30-D8DD767FBA77Q33999073-57094264-DF3A-48D8-A0D0-2BCCD13EFBE6Q34093125-0705D2A1-3C00-4B97-92F6-E2331FD1924BQ34211879-2C0074D7-90CA-4CD2-A9F4-F122D81CD8C7Q34277606-4E77FC8D-C5DC-471C-B956-E2FF83580B1BQ34287068-A56223B6-3BCA-45A2-86A3-68F48354C76DQ34309546-1856C649-E0A8-492A-9DA1-5240720685B9Q34336095-74753851-8D7B-4B0B-AB01-2E5AA1520623Q34392810-6318DED0-87FB-4354-B3B6-9527B8C713DDQ34433806-E34894F6-E27C-47F0-B8FF-CE613A598114Q34485079-587173CD-4426-42ED-92BC-89AA82CBCCE2Q34489396-1B0432D5-CA96-432E-A984-AACEB8A48E35Q34537257-874FEC5A-62C1-48F8-99C7-EEB16158A6D0Q34552025-0654FCE3-FA35-4B08-9BD8-3C12EC1DE890Q34622433-04760235-EF28-4C07-9706-25E1CC5A3A2F
P2860
The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The E-cadherin/catenin complex ...... esis and malignant progression
@nl
The E-cadherin/catenin complex ...... sis and malignant progression.
@ast
The E-cadherin/catenin complex ...... sis and malignant progression.
@en
type
label
The E-cadherin/catenin complex ...... esis and malignant progression
@nl
The E-cadherin/catenin complex ...... sis and malignant progression.
@ast
The E-cadherin/catenin complex ...... sis and malignant progression.
@en
prefLabel
The E-cadherin/catenin complex ...... esis and malignant progression
@nl
The E-cadherin/catenin complex ...... sis and malignant progression.
@ast
The E-cadherin/catenin complex ...... sis and malignant progression.
@en
P2860
P921
P3181
P356
P1476
The E-cadherin/catenin complex ...... sis and malignant progression.
@en
P2093
P2860
P2888
P304
P3181
P356
10.1186/BCR309
P407
P50
P577
2001-06-28T00:00:00Z
P5875
P6179
1052733880